TLX ASX Chart
Snapshot
Telix Pharmaceuticals Limited (TLX) is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. Telix is developing a portfolio of clinical stage products that aims to address unmet medical needs in oncology and rare diseases.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +44.86% |
vs ASX 200 (1yr) | +34.87% |
Latest TELIX Pharmaceuticals Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | North Melbourne VIC 3051 |
Website | www.telixpharma.com |
Registry | Link Market Services |
Auditor | PricewaterhouseCoopers |
Date Listed | 15 Nov 2017 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
22/05/2024 | AGM |
21/08/2024 | Report (Interim) |
20/02/2025 | Report (Prelim) |
20/02/2025 | Report (Annual) |
Former Company Names
- TELIX Pharmaceuticals Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
TLX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of TLX directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Elk River Holdings Pty Ltd | 24/01/2024 | 22,675,000 | 7.00 |
HSBC Custody Nominees (Australia) Limited | 24/01/2024 | 38,850,342 | 11.99 |
Gnosis Verwaltungsgesellschaft | 24/01/2024 | 22,675,000 | 7.00 |
J P Morgan Nominees Australia Pty Limited | 24/01/2024 | 34,966,849 | 10.79 |
Citicorp Nominees Pty Limited | 24/01/2024 | 29,118,387 | 8.99 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $11.22 | 30 June |
2022 | $4.53 | 30 June |
2021 | $6.09 | 30 June |
2020 | $1.28 | 30 June |
2019 | $1.24 | 28 June |
2018 | $0.670 | 29 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.